Universities' experience with mumps outbreak response and use of a third dose of MMR vaccine.
J Am Coll Health
; 69(1): 53-58, 2021 01.
Article
en En
| MEDLINE
| ID: mdl-31478806
ABSTRACT
OBJECTIVE:
During January 2016-June 2017, 75 mumps outbreaks occurred in US universities, despite high vaccine coverage among students. We evaluated universities' experiences with mumps outbreaks to inform policy deliberations on use of a third dose of MMR vaccine and CDC guidance.Participants:
American College Health Association members in September 2017.Methods:
Online survey assessing mumps outbreak characteristics and response measures distributed to 980 members.Results:
Administrators from 251 (26%) universities from 47 states responded. Seventy-nine (31%) universities had mumps cases on campus during August 2014-August 2017; 17 (22%) recommended a third MMR dose. The main challenges reported in outbreak response were exclusion of persons without presumptive immunity and isolation of students with mumps. Universities' advice on addressing challenges is described.Conclusion:
We identified common challenges faced by universities during mumps outbreaks, and lessons learned. These findings informed the October 2017 recommendation for use of a third MMR dose.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vacuna contra el Sarampión-Parotiditis-Rubéola
/
Paperas
Tipo de estudio:
Prognostic_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Am Coll Health
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos